Compile Data Set for Download or QSAR
Found 151 with Last Name = 'pettersson' and Initial = 'h'
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29098(dibenzothiazepine, 12e)copy SMILEScopy InChI
Affinity DataKi:  0.200nM ΔG°:  -54.8kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29100(dibenzothiazepine, 12h)copy SMILEScopy InChI
Affinity DataKi:  0.200nM ΔG°:  -54.8kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29096(dibenzothiazepine, 12b)copy SMILEScopy InChI
Affinity DataKi:  0.320nM ΔG°:  -53.6kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29097(dibenzothiazepine, 12c)copy SMILEScopy InChI
Affinity DataKi:  0.790nM ΔG°:  -51.4kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29101(dibenzothiazepine, 12j)copy SMILEScopy InChI
Affinity DataKi:  1.20nM ΔG°:  -50.4kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29102(dibenzothiazepine, 12k)copy SMILEScopy InChI
Affinity DataKi:  1.60nM ΔG°:  -49.7kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM21278(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl...)copy SMILEScopy InChI
Affinity DataKi:  2nM ΔG°:  -49.2kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMedDrugBank
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29095(dibenzothiazepine, 12a)copy SMILEScopy InChI
Affinity DataKi:  3nM ΔG°:  -48.2kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29094((+/-)-SLV319 | (S)-3-(4-chlorophenyl)-N-(4-chlorop...)copy SMILEScopy InChI
Affinity DataKi:  3nM ΔG°:  -48.2kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29099(dibenzothiazepine, 12g)copy SMILEScopy InChI
Affinity DataKi:  25nM ΔG°:  -43.0kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29103(dibenzothiazepine, 13)copy SMILEScopy InChI
Affinity DataKi:  40nM ΔG°:  -41.8kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM21278(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl...)copy SMILEScopy InChI
Affinity DataKi:  398nM ΔG°:  -36.2kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29100(dibenzothiazepine, 12h)copy SMILEScopy InChI
Affinity DataKi:  1.00E+3nM ΔG°:  -33.9kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29097(dibenzothiazepine, 12c)copy SMILEScopy InChI
Affinity DataKi:  1.26E+3nM ΔG°:  -33.3kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29094((+/-)-SLV319 | (S)-3-(4-chlorophenyl)-N-(4-chlorop...)copy SMILEScopy InChI
Affinity DataKi:  2.00E+3nM ΔG°:  -32.2kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
ACADIA Pharmaceuticals AB

LigandPNGBDBM29099(dibenzothiazepine, 12g)copy SMILEScopy InChI
Affinity DataKi:  5.01E+3nM ΔG°:  -29.9kJ/molepH: 7.2 T: 2°CAssay Description:IC50 values for test compounds were determined from nonlinear regression analysis of data collected from ligand displacement experiments. The inhibit...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q25Q4TFPPubMed
LigandPNGBDBM14774(3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl...)copy SMILEScopy InChI
Affinity DataIC50: 0.5nMAssay Description:Inhibition of PDE4 (unknown origin)More data for this Ligand-Target Pair
LigandPNGBDBM50548547(CHEMBL4784121)copy SMILES
Affinity DataIC50: 0.680nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548547(CHEMBL4784121)copy SMILES
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548531(CHEMBL4747201)copy SMILES
Affinity DataIC50: 1.20nMAssay Description:Inhibition of human PDE4A catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548531(CHEMBL4747201)copy SMILES
Affinity DataIC50: 1.20nMAssay Description:Inhibition of human PDE4B catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM130923(US8829190, 101)copy SMILEScopy InChI
Affinity DataIC50: 1.70nMAssay Description:Inhibition of PDE4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548527(CHEMBL4740828)copy SMILES
Affinity DataIC50: 2nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548555(CHEMBL4779112)copy SMILES
Affinity DataIC50: 2.10nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548528(CHEMBL4740242)copy SMILES
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548526(CHEMBL4750576)copy SMILES
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50048446(CHEMBL3315088)copy SMILEScopy InChI
Affinity DataIC50: 2.80nMAssay Description:Inhibition of PDE4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548527(CHEMBL4740828)copy SMILES
Affinity DataIC50: 2.90nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548531(CHEMBL4747201)copy SMILES
Affinity DataIC50: 3nMAssay Description:Inhibition of human PDE4C catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548528(CHEMBL4740242)copy SMILES
Affinity DataIC50: 3.40nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548555(CHEMBL4779112)copy SMILES
Affinity DataIC50: 3.60nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548531(CHEMBL4747201)copy SMILES
Affinity DataIC50: 3.80nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548526(CHEMBL4750576)copy SMILES
Affinity DataIC50: 3.90nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548533(CHEMBL4739987)copy SMILES
Affinity DataIC50: 4.5nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548533(CHEMBL4739987)copy SMILES
Affinity DataIC50: 4.5nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548543(CHEMBL4741065)copy SMILES
Affinity DataIC50: 5.10nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548532(CHEMBL4764289)copy SMILES
Affinity DataIC50: 5.70nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548531(CHEMBL4747201)copy SMILES
Affinity DataIC50: 6nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548534(CHEMBL4761069)copy SMILES
Affinity DataIC50: 6nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548532(CHEMBL4764289)copy SMILES
Affinity DataIC50: 6.40nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548511(CHEMBL4744621)copy SMILES
Affinity DataIC50: 7nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548553(CHEMBL4795054)copy SMILES
Affinity DataIC50: 7.40nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548529(CHEMBL4745874)copy SMILES
Affinity DataIC50: 8nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548534(CHEMBL4761069)copy SMILES
Affinity DataIC50: 8nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548566(CHEMBL4796321)copy SMILES
Affinity DataIC50: 8nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548509(CHEMBL4792140)copy SMILES
Affinity DataIC50: 9nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548530(CHEMBL4753953)copy SMILES
Affinity DataIC50: 9nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548529(CHEMBL4745874)copy SMILES
Affinity DataIC50: 9.20nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548523(CHEMBL4782606)copy SMILES
Affinity DataIC50: 12nMAssay Description:Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
LigandPNGBDBM50548536(CHEMBL4759431)copy SMILES
Affinity DataIC50: 12nMAssay Description:Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2T43XPQPubMed
Displayed 1 to 50 (of 151 total ) | Next | Last >>
Jump to: